Financial Statement Analysis
Grant Date: The One Date in Your Equity Plan That Changes Everything
My brother-in-law spent two and a half years at a startup before it was acquired. When the payout calculations came through, he was surprised to find that a colleague who joined six months after him walked away with a noticeably larger equity payout, despite holding the same number of options. Same company. Same exit price. Completely different outcome.
The reason came down to one thing. Their grant dates were different, which meant their base prices were different, which meant the appreciation being paid out was calculated from different starting points.
He had never paid much attention to his grant date when he signed his award letter. Most people do not. But that single date quietly shaped everything about how his equity ultimately paid out.
So What Is a Grant Date
Put simply, it is the official date on which the company hands you an equity award. Not the date you started negotiating it. Not the date HR mentioned it in your offer conversation. The date the company formally, legally, made the award and you were told the specific terms.
From that moment, several things lock in. The base price or exercise price of your award is fixed. Your vesting clock begins ticking. The accounting and tax treatment of the award is anchored to that date. Every other number that matters in your equity plan flows from this one starting point.
Think of it as the starting line of a race. Everything that happens before it is just warm-up. Everything after it is performance.
Why the Base Price Connection Matters So Much
When a company grants share options or stock appreciation rights, the base price is almost always set at whatever the shares are worth on the grant date itself. This is deliberately designed to ensure employees only profit if the company genuinely grows from that point forward.
The practical consequence is straightforward. If your grant date falls when the company’s valuation is high, you need more growth before seeing any payout. If it falls during a quieter period, the same eventual exit price will generate a larger return for you.
This is not a minor technicality. In a fast-growing company, the difference between a grant date in January versus one in October of the same year could translate into a meaningfully different base price and therefore a meaningfully different payout at exit. My brother-in-law’s colleague joined during a period when the company’s valuation had dipped slightly. His options were anchored to a lower base. Same exit, larger gain.
When Does the Grant Date Actually Happen
This is where things get more complicated than most employees realise.
In listed companies, boards typically grant awards at set points in the calendar, usually after earnings announcements or at the start of the financial year. The reason for this predictability is partly administrative and partly ethical. Granting options just before a positive announcement, when the share price is still low, would hand executives an unfair advantage. So most governance frameworks require awards to be made during defined windows, away from periods when insiders might have sensitive information.
The formal requirement is that the board or compensation committee must have actually approved the award before the grant date is recorded. And critically, the employee must have been told the terms. Under international accounting standards, a grant date only exists once both parties, the company and the employee, have a shared understanding of what has been awarded. If you sign your award letter weeks after the board approved it, the accounting grant date could be your signature date, not the board approval date.
For private companies, this gets messier. There is no market price to reference, so the company has to determine what its shares are worth on the grant date. This usually means anchoring to the most recent funding round, commissioning an independent valuation, or using a board-agreed formula. Getting this right matters because if the grant date price is later challenged as inaccurate, the tax treatment of the award can unravel badly for the employee.
The Backdating Scandal That Changed Everything
In the mid-2000s, researchers in the United States noticed something statistically strange. Executive option grants were consistently being made just before periods of strong share price growth, and just after periods of decline. The pattern was far too consistent to be coincidence.
What had been happening was backdating. Companies were looking back at historical share price charts, picking dates where the price had been low, and recording grants as having been made on those dates, even though the actual decision happened later. The effect was to hand executives options that were already in the money before a single day of future performance had occurred.
When investigators dug in, they found hundreds of companies involved. Executives faced criminal charges. Companies restated years of financial statements. Careers ended.
The entire episode came down to dishonest manipulation of one date on one document. It demonstrated in the most dramatic way possible that the grant date is not just an administrative entry. It is the financial and legal foundation of the award. Changing it retrospectively, or choosing it with access to information other investors do not have, is fraud.
The aftermath was a wave of regulation requiring contemporaneous documentation, mandatory disclosure windows, and strict governance over when grants can and cannot be made. Those rules exist today specifically because of what happened when companies treated the grant date casually.
How It Flows Into Accounting
Under the international accounting standard that governs equity compensation, known as IFRS 2, the fair value of an equity-settled award is measured on the grant date and that figure becomes the fixed compensation expense recognised over the vesting period.
This means the company’s income statement carries a charge based on what the options were worth on the day they were granted, regardless of what subsequently happens to the share price. If the options later double in potential value, the accounting charge does not increase. If the share price collapses and the options become worthless, the accounting charge already recognised is not reversed.
For companies settling awards in cash rather than shares, the treatment is different. The liability is remeasured at fair value at every reporting date. So a rising share price after the grant date creates a growing liability on the balance sheet and an increasing charge through the income statement. This accounting volatility is one reason some companies prefer equity-settled structures over cash-settled ones.
The fair value calculation at grant date typically uses an option pricing model. For straightforward awards in listed companies, Black-Scholes is the standard. For more complex instruments with performance conditions, Monte Carlo simulations are used. The key inputs are the share price on the grant date, the base price, the expected life of the award, expected volatility, and the risk-free rate.
The Tax Picture
In most tax systems, receiving an equity award on the grant date does not itself trigger a tax event. The employee has been given something that might become valuable, but it depends on future performance and vesting. Taxing a contingent promise at the moment it is made would be both administratively difficult and potentially unfair.
Tax typically arises later, at vesting or at exercise, and is usually treated as employment income rather than a capital gain. This distinction matters because employment income tax rates tend to be higher than capital gains rates in most jurisdictions.
There are situations where an election to be taxed at grant date can be beneficial. If the award is already worth something on grant date and the employee expects significant growth, paying a smaller tax bill now based on the current value rather than a larger one later based on the appreciated value can make financial sense. But this requires paying real tax on something that has not yet delivered cash, which is a genuine risk if the company does not perform as expected.
The base price set on the grant date also matters for determining whether the award qualifies for any favourable tax treatment. Options granted at a meaningful discount to market value on the grant date are often denied the tax reliefs available to market-rate grants. This is another reason why private companies need to take care in establishing a defensible valuation on each grant date.
What Employees Should Actually Do
Most employees receive their equity award documentation, sign it, file it somewhere, and forget about it until something happens. That is understandable but not ideal.
The grant date and the base price deserve a moment of proper attention when the award arrives. Understanding what those numbers mean, specifically what share price or company valuation the award needs to reach before it pays out anything, is basic information for anyone making decisions about their career and compensation.
The vesting schedule also deserves careful reading. It runs from the grant date, not from your start date or the date you were first told about the award. If there was a delay between joining and receiving your formal grant documentation, months of vesting time may have already slipped by before the clock even started.
Knowing the expiry date of your award matters particularly if you ever leave the company. Most equity awards give departing employees a limited window, sometimes as short as ninety days, to exercise vested options after leaving. That window is measured from the date of departure, not the grant date, but the expiry date of the award itself is set relative to the grant date. Missing either deadline means losing instruments that were legitimately earned.
A Final Thought
My brother-in-law is philosophical about what happened. The colleague with the better grant date timing was not smarter or more valuable to the business. The timing was mostly coincidence. But it produced a real financial difference at exit.
What he took away from the experience was not resentment but awareness. When he joined his next company and received a new equity plan, he read the documentation carefully. He noted the grant date, understood the base price, and asked his accountant about the tax implications specific to his situation.
The grant date was still just a date on a document. But he understood what it meant this time, and that understanding put him in a much better position to evaluate what he had actually been given.
That is really all this comes down to. One date, clearly understood, makes the difference between treating equity compensation as a vague promise and treating it as a concrete financial entitlement with specific mechanics worth knowing.
